Retinoids as Anti-cancer Agents in Breast Cancer

Retinoids as Anti-cancer Agents in Breast Cancer by Manzoor Ahmad Mir is a compelling, rigorously researched contribution for clinicians, researchers, and graduate students focused on breast cancer therapeutics. Clear, authoritative, and up-to-date, this book unpacks the science of retinoids—vitamin A derivatives—and their evolving role as anti-cancer agents in breast oncology.

From the first page, readers are drawn into a vivid overview of molecular mechanisms: retinoid signaling pathways, receptor biology, modulation of cell differentiation and apoptosis, and interactions with hormone-driven tumor subtypes. Manzoor Ahmad Mir synthesizes preclinical data and clinical trial evidence to illuminate where retinoids show promise, where challenges remain, and how combination strategies and biomarker-driven approaches can optimize outcomes.

Practical and forward-looking, the book translates complex laboratory findings into translational insights useful to oncologists, translational researchers, and pharmaceutical scientists. Detailed discussions cover resistance mechanisms, dosing strategies, safety profiles, and design considerations for future clinical studies—making it a valuable reference for those developing therapeutic protocols or planning research across regions including North America, Europe, Asia-Pacific, and beyond.

Whether you’re seeking a concise scientific primer or a thorough resource for grant writing and study design, this volume balances depth with clarity. Its authoritative voice helps readers evaluate the current landscape and envision next steps in retinoid research for breast cancer care.

Add this essential volume by Manzoor Ahmad Mir to your professional library to stay informed on one of the most intriguing avenues in oncology research—order now to explore the full potential of retinoids in breast cancer therapy.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.